Anal cancer is a rare yet increasing cancer linked primarily to high-risk HPV strains such as HPV-16 and HPV-18. Key risk factors include weakened immune systems, age over 50, and high-risk sexual ...

Losing British drug giant AstraZeneca from the London Stock Exchange would be a “devastating blow”, Tory former chancellor ...

Cheng was a pioneer in clinical trials for tumour diseases, especially small-cell lung carcinoma A top Chinese oncologist and physician-scientist, Cheng Ying, has died suddenly aged 62, according to ...

The Lancet on the anti-IL-5 antibody mepolizumab in individuals with allergic asthma, evidence has accumulated that the pathogenetic role of eosinophils is fundamentally different between asthma ...

The company's share price has received a boost in recent weeks after it was declared the successful bidder for UK small ...

London has struggled for several years to attract big-name IPOs amid a dearth of liquidity and a less favourable regulatory ...

In 2025, AstraZeneca continues to impress me with the strong performances of its oncology, cardiovascular, and rare disease franchises. See why AZN stock is a Buy.

A Google Translate screenshot correctly shows that the name of the pharmaceutical company AstraZeneca, when written as “A stra ze neca,” means “a road to death” in Latin.

Investors in AstraZeneca plc (Symbol: AZN) saw new options become available today, for the June 27th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AZN ...

These investments have also included the expansion of AstraZeneca’s Global Research and Development (R&D) Hub and the creation of a new Alexion R&D Hub focused on rare disease research. With a 70-year ...